The Global Neuromodulation Devices Market research report is the study prepared by analysts, which
contain a detailed analysis of drivers, restraints, and opportunities along with their impact on the
Neuromodulation Devices Market growth (2019 - 2023).
Neuromodulation is a prominent technology which is used to stimulate specific neurological sites or
alteration of the nerve activity by using electricity or chemical agents in the body. Most of these devices
are using electrical stimulation. Electrodes are attached to the brain, spinal cord, or peripheral nerves
for carrying out the procedure.
Factors such as extended new indications and target applications coupled with the robust product
pipeline offered by players and increasing prevalence of neurological diseases are expected to drive the
growth over the forecast period. Furthermore, the expansion in emerging economies is expected to
create significant growth opportunities for players operating in the neuromodulation market.
Major Players profiled in the Neuromodulation Devices Market report incorporate: Medtronic, Boston
Scientific, St. Jude Medical (Abbott), LivaNova, Nevro, NeuroPace, Beijing Pins, Synapse Biomedical
Top Industry
Boston Scientific Corporation (NYSE: BSX) today announced that the first patient in the PRISM
(Precision® Implantable Stimulator for Migraine) clinical trial was implanted. This pivotal trial will assess
the safety and efficacy of occipital nerve stimulation as a treatment for refractory migraine headache,
and will use Boston Scientific's Precision™ neurostimulation system to treat migraine patients who do
not respond to other available therapies, or who cannot tolerate the side effects of existing medications.
The Precision® implantable pulse generator will deliver electrical impulses to the occipital nerves located
just under the skin at the back of the neck.
Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on
“Global Neuromodulation Devices Market Report 2019” @
https://www.businessindustryreports.com/buy-now/173400/single .
Region segment: This report is segmented into several key regions, with sales, revenue, market share
(%) and growth Rate (%) of Neuromodulation Devices in these regions, from 2014 to 2023 (forecast),
covering: North America, Europe, Asia Pacific, Middle East & Africa and South America.
The report is a compilation of first-hand information, qualitative and quantitative assessment by
industry analysts, inputs from industry experts and industry participants across the value chain. The
report provides in-depth analysis of parent market trends, macro-economic indicators and governing
factors along with market attractiveness as per segments. The report also maps the qualitative impact of
various market factors on market segments and geographies.
Significant points in table of contents: Market Definition, Market Overview, Business Introduction,
Segmentation (Region Level), Segmentation (Type Level), Segmentation (Industry Level), Segmentation
(Channel Level), Market Forecast Year, Segmentation Type, Segmentation Industry, Market Cost
Analysis, and Conclusion.